PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"30952982","Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, Zhou X, Wang C, Xue Y, Cui Y, Xu J.","Nat Biomed Eng. 2019 Apr;3(4):306-317. doi: 10.1038/s41551-019-0375-6. Epub 2019 Mar 25.","Yao H","Nat Biomed Eng","2019","2019/04/07","","","10.1038/s41551-019-0375-6"
"29596064","Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis","Liao CP, Booker RC, Brosseau JP, Chen Z, Mo J, Tchegnon E, Wang Y, Clapp DW, Le LQ.","J Clin Invest. 2018 Jul 2;128(7):2848-2861. doi: 10.1172/JCI99424. Epub 2018 May 21.","Liao CP","J Clin Invest","2018","2018/03/30","PMC6025974","","10.1172/JCI99424"
"31474359","Heterozygous Tumor Suppressor Microenvironment in Cancer Development","Brosseau JP, Le LQ.","Trends Cancer. 2019 Sep;5(9):541-546. doi: 10.1016/j.trecan.2019.07.004. Epub 2019 Aug 15.","Brosseau JP","Trends Cancer","2019","2019/09/03","PMC6724550","NIHMS1535455","10.1016/j.trecan.2019.07.004"
"32185714","Regulations on Messenger RNA: Wires and Nodes","Brosseau JP.","Adv Exp Med Biol. 2020;1248:251-263. doi: 10.1007/978-981-15-3266-5_11.","Brosseau JP","Adv Exp Med Biol","2020","2020/03/19","","","10.1007/978-981-15-3266-5_11"
"34445326","Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development","Mohamad T, Plante C, Brosseau JP.","Int J Mol Sci. 2021 Aug 10;22(16):8620. doi: 10.3390/ijms22168620.","Mohamad T","Int J Mol Sci","2021","2021/08/27","PMC8395254","","10.3390/ijms22168620"
"33024277","Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy","Xu J, Brosseau JP, Shi H.","Oncogene. 2020 Nov;39(48):7106-7113. doi: 10.1038/s41388-020-01491-w. Epub 2020 Oct 6.","Xu J","Oncogene","2020","2020/10/07","","","10.1038/s41388-020-01491-w"
"32439933","Translating current basic research into future therapies for neurofibromatosis type 1","Brosseau JP, Liao CP, Le LQ.","Br J Cancer. 2020 Jul;123(2):178-186. doi: 10.1038/s41416-020-0903-x. Epub 2020 May 22.","Brosseau JP","Br J Cancer","2020","2020/05/23","PMC7374719","","10.1038/s41416-020-0903-x"
"33413690","Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing","Brosseau JP, Sathe AA, Wang Y, Nguyen T, Glass DA 2nd, Xing C, Le LQ.","Acta Neuropathol Commun. 2021 Jan 7;9(1):11. doi: 10.1186/s40478-020-01103-4.","Brosseau JP","Acta Neuropathol Commun","2021","2021/01/08","PMC7792184","","10.1186/s40478-020-01103-4"
"34458782","A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions","Yao H, Li C, He F, Song T, Brosseau JP, Wang H, Lu H, Fang C, Shi H, Lan J, Fang JY, Xu J.","RSC Chem Biol. 2020 Nov 3;2(1):192-205. doi: 10.1039/d0cb00157k. eCollection 2021 Feb 1.","Yao H","RSC Chem Biol","2020","2021/08/30","PMC8341464","","10.1039/d0cb00157k"
"24335142","Tumor microenvironment-associated modifications of alternative splicing","Brosseau JP, Lucier JF, Nwilati H, Thibault P, Garneau D, Gendron D, Durand M, Couture S, Lapointe E, Prinos P, Klinck R, Perreault JP, Chabot B, Abou-Elela S.","RNA. 2014 Feb;20(2):189-201. doi: 10.1261/rna.042168.113. Epub 2013 Dec 11.","Brosseau JP","RNA","2014","2013/12/17","PMC3895271","","10.1261/rna.042168.113"
"24375754","Redirecting splicing with bifunctional oligonucleotides","Brosseau JP, Lucier JF, Lamarche AA, Shkreta L, Gendron D, Lapointe E, Thibault P, Paquet E, Perreault JP, Abou Elela S, Chabot B.","Nucleic Acids Res. 2014 Apr;42(6):e40. doi: 10.1093/nar/gkt1287. Epub 2013 Dec 26.","Brosseau JP","Nucleic Acids Res","2014","2013/12/31","PMC3973305","","10.1093/nar/gkt1287"
"20038630","High-throughput quantification of splicing isoforms","Brosseau JP, Lucier JF, Lapointe E, Durand M, Gendron D, Gervais-Bird J, Tremblay K, Perreault JP, Elela SA.","RNA. 2010 Feb;16(2):442-9. doi: 10.1261/rna.1877010. Epub 2009 Dec 28.","Brosseau JP","RNA","2010","2009/12/30","PMC2811672","","10.1261/rna.1877010"
"23425137","8-BuS-ATP derivatives as specific NTPDase1 inhibitors","Lecka J, Gillerman I, Fausther M, Salem M, Munkonda MN, Brosseau JP, Cadot C, Martín-Satué M, d'Orléans-Juste P, Rousseau E, Poirier D, Künzli B, Fischer B, Sévigny J.","Br J Pharmacol. 2013 May;169(1):179-96. doi: 10.1111/bph.12135.","Lecka J","Br J Pharmacol","2013","2013/02/22","PMC3632248","","10.1111/bph.12135"
"30976071","Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, Zhou X, Wang C, Xue Y, Cui Y, Xu J.","Nat Biomed Eng. 2019 May;3(5):414. doi: 10.1038/s41551-019-0402-7.","Yao H","Nat Biomed Eng","2019","2019/04/13","","","10.1038/s41551-019-0402-7"
"30479396","NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation","Brosseau JP, Liao CP, Wang Y, Ramani V, Vandergriff T, Lee M, Patel A, Ariizumi K, Le LQ.","Nat Commun. 2018 Nov 27;9(1):5014. doi: 10.1038/s41467-018-07452-y.","Brosseau JP","Nat Commun","2018","2018/11/28","PMC6258697","","10.1038/s41467-018-07452-y"
"32960816","Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling","Chen Z, Li S, Mo J, Hawley E, Wang Y, He Y, Brosseau JP, Shipman T, Clapp DW, Carroll TJ, Le LQ.","JCI Insight. 2020 Oct 15;5(20):e141514. doi: 10.1172/jci.insight.141514.","Chen Z","JCI Insight","2020","2020/09/22","PMC7605536","","10.1172/jci.insight.141514"
"29987131","The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities","Brosseau JP, Pichard DC, Legius EH, Wolkenstein P, Lavker RM, Blakeley JO, Riccardi VM, Verma SK, Brownell I, Le LQ.","Neurology. 2018 Jul 10;91(2 Suppl 1):S14-S20. doi: 10.1212/WNL.0000000000005788.","Brosseau JP","Neurology","2018","2018/07/11","PMC9703338","","10.1212/WNL.0000000000005788"
"21552259","Alternative splicing of SYK regulates mitosis and cell survival","Prinos P, Garneau D, Lucier JF, Gendron D, Couture S, Boivin M, Brosseau JP, Lapointe E, Thibault P, Durand M, Tremblay K, Gervais-Bird J, Nwilati H, Klinck R, Chabot B, Perreault JP, Wellinger RJ, Elela SA.","Nat Struct Mol Biol. 2011 Jun;18(6):673-9. doi: 10.1038/nsmb.2040. Epub 2011 May 8.","Prinos P","Nat Struct Mol Biol","2011","2011/05/10","","","10.1038/nsmb.2040"
"19400258","Design, synthesis and pharmacological characterization of fluorescein-derived endothelin antagonists Bq-123 and Bq-788","Brosseau JP, Neugebauer WA, Gobeil F Jr, D'Orléans-Juste P.","Adv Exp Med Biol. 2009;611:443-4. doi: 10.1007/978-0-387-73657-0_191.","Brosseau JP","Adv Exp Med Biol","2009","2009/04/30","","","10.1007/978-0-387-73657-0_191"
"19010929","Identification of alternative splicing markers for breast cancer","Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Koh C, Gervais-Bird J, Lapointe E, Froehlich U, Durand M, Gendron D, Brosseau JP, Thibault P, Lucier JF, Tremblay K, Prinos P, Wellinger RJ, Chabot B, Rancourt C, Elela SA.","Cancer Res. 2008 Nov 15;68(22):9525-31. doi: 10.1158/0008-5472.CAN-08-1769.","Venables JP","Cancer Res","2008","2008/11/18","","","10.1158/0008-5472.CAN-08-1769"
"23149937","RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues","Venables JP, Brosseau JP, Gadea G, Klinck R, Prinos P, Beaulieu JF, Lapointe E, Durand M, Thibault P, Tremblay K, Rousset F, Tazi J, Abou Elela S, Chabot B.","Mol Cell Biol. 2013 Jan;33(2):396-405. doi: 10.1128/MCB.01174-12. Epub 2012 Nov 12.","Venables JP","Mol Cell Biol","2013","2012/11/15","PMC3554129","","10.1128/MCB.01174-12"
"30348677","Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway","Chen Z, Mo J, Brosseau JP, Shipman T, Wang Y, Liao CP, Cooper JM, Allaway RJ, Gosline SJC, Guinney J, Carroll TJ, Le LQ.","Cancer Discov. 2019 Jan;9(1):114-129. doi: 10.1158/2159-8290.CD-18-0151. Epub 2018 Oct 22.","Chen Z","Cancer Discov","2019","2018/10/24","PMC6328325","NIHMS1508051","10.1158/2159-8290.CD-18-0151"
"16042984","Development of an efficient strategy for the synthesis of the ETB receptor antagonist BQ-788 and some related analogues","Brosseau JP, D'Orléans-Juste P, Neugebauer WA.","Peptides. 2005 Aug;26(8):1441-53. doi: 10.1016/j.peptides.2005.03.022. Epub 2005 Apr 25.","Brosseau JP","Peptides","2005","2005/07/27","","","10.1016/j.peptides.2005.03.022"
